As obesity rates continue to rise and the US contends with a growing aging population, the need for diabetes risk identification, prevention, and management is more critical than ever.1
Quest Diagnostics offers a comprehensive array of laboratory testing for diabetes to help you manage the disease in all of your patients, no matter where they are on the care continuum, ensuring continuity of care.
Start the right treatment plan with a differential diagnosis that goes beyond diabetes type 1 and type 2, including latent autoimmune diabetes in adults (LADA) and monogenic diabetes (MODY).
Rely on our testing based on guidelines issued by the American Diabetes Association (ADA) to effectively monitor and manage diabetes patients and help them delay or avoid the potential for complications.
With more people at risk for cardiovascular disease than ever before, the Quest Cardiometabolic Center of Excellence™ at Cleveland HeartLab® is advancing a prevention-focused approach for heart disease and associated metabolic conditions.
Cardiovascular disease (CVD) is strongly associated with type 2 diabetes (T2DM), chronic kidney disease (CKD), and nonalcoholic fatty liver disease (NAFLD). Through significant investments in novel technology, the Cleveland HeartLab® is fostering innovation to detect these conditions in their early stages, providing the opportunity for stage-targeted intervention and improved clinical outcomes.
This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.